Schedule 13G ownership disclosure

Flex Pharma, Inc.

Security class unavailable · CUSIP: 33938A105

Event date: 2016-10-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
994,900
Percent of class
5.5400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-16-155775
Form type
SC 13G
Filer
Decoy Therapeutics Inc.
CIK
CIK 1615219
Filed
Nov 09, 2016
Reporting period
Oct 31, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub